OAKLAND, Calif.--(BUSINESS WIRE)--Shares of The Chemours Company (“Chemours”) dropped over 12% in intraday trading on February 14, 2024, after announcing it is evaluating its internal control over financial reporting and postponing its fourth quarter and full year 2023 financial results. Gibbs Law Group is investigating a potential Chemours Company Securities Class Action Lawsuit on behalf of shareholders who lost money in The Chemours Company (NYSE: CC). What Should Chemours Company Investors Do? If yo ...